Viking Therapeutics (VKTX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

VKTX is expected to report earnings to rise 38.85% to -27 cents per share on October 30

Viking Therapeutics VKTX Stock Earnings Reports

Q3'24

Est.

$-0.28

Q2'24

Beat

by $0.06

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.01

Q3'23

Missed

by $0.01

The last earnings report on July 24 showed earnings per share of -20 cents, beating the estimate of -25 cents. With 1.83M shares outstanding, the current market capitalization sits at 6.83B.

View a ticker or compare two or three

Compare

VKTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VKTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for VKTX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company that engages in the development of therapies for metabolic and endocrine disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9920 Pacific Heights Boulevard

Phone

+1 858 704-4660

Employees

Web

https://www.vikingtherapeutics.com